Cargando…
Antiviral activity of triptolide on herpes simplex virus in vitro
BACKGROUND: Herpes simplex virus‐type 1 (HSV‐1) can cause diseases, especially amongst neonates and immunocompromised hosts. Hence, developing a novel anti‐HSV‐1 drug with low‐level toxicity is vital. Triptolide (TP), a diterpenoid triepoxide is a natural product with range of bioactivity qualities....
Autores principales: | Aliabadi, Nasrin, Jamalidoust, Marzieh, Pouladfar, Gholamreza, Ziyaeyan, Atoosa, Ziyaeyan, Mazyar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208287/ https://www.ncbi.nlm.nih.gov/pubmed/35759241 http://dx.doi.org/10.1002/iid3.667 |
Ejemplares similares
-
Evaluating the therapeutic efficacy of triptolide and (S)-10-hydroxycamptothecin on cutaneous and ocular Herpes Simplex Virus type-1 infections in mice
por: Aliabadi, Nasrin, et al.
Publicado: (2022) -
Diagnosing of Herpes Simplex Virus Infections in Suspected Patients Using Real-Time PCR
por: Aliabadi, Nasrin, et al.
Publicado: (2015) -
Characterization and phylogenetic analysis of Iranian SARS‐CoV‐2 genomes: A phylogenomic study
por: Aliabadi, Nasrin, et al.
Publicado: (2023) -
Widespread circulation of West Nile virus, but not Zika virus in southern Iran
por: Ziyaeyan, Mazyar, et al.
Publicado: (2018) -
The rates and symptoms of natural and breakthrough infection pre- and post- Covid-19 non-mRNA vaccination at various peaks amongst Iranian healthcare workers
por: Jamalidoust, Marzieh, et al.
Publicado: (2023)